Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 262 for “"Bone disease"”.

  1. Acidosis and bone disease in chronic renal failure

    … connection existed between acidosis and renal bone disease. We know that most creatures exposed to direct sunlight have evolved a metabolism that far from accumulating Vitamin D, tends rather to inactivate and excrete it, presumably to reduce the risk of toxic effects. Perhaps for similar …

    birmingham Download PDF for Acidosis and bone disease in chronic renal failure (opens in a new tab)

  2. In vitro studies with bone in metabolic bone disease

    … one in particular is of interest in this thesis; bone loss and the problems of metabolic bone disease, leading to various studies concerned with their effects on bone and bone metabolism. Organ culture preparations of neonatal mouse calvaria were used to look at several aspects of bone metabolism. …

    glasgow Download PDF for In vitro studies with bone in metabolic bone disease (opens in a new tab)

  3. A Functional Three-Dimensional Microphysiological Model of Myeloma Bone Disease

    … infiltrates the skeleton at several sites. The disease is characterized by uninhibited transformed plasma cell proliferation that disrupts skeletal homeostasis leading to decreased bone modeling and increased bone resorption. Osteolytic lesions (OL) or voids left in the bone, remain long after …

    shu-thes Repository record for A Functional Three-Dimensional Microphysiological Model of Myeloma Bone Disease (opens in a new tab)

  4. Skeletal scintigraphy and quantitative tracer studies in metabolic bone disease

    Bone scan imaging with the current bone seeking radiopharmaceuticals, the technetium-99m labelled diphosphonates, has dramatically improved our ability to evaluate skeletal pathology. In this thesis, chapter 1 presents a review of the history of bone scanning, summarises present concepts as to the …

    glasgow Download PDF for Skeletal scintigraphy and quantitative tracer studies in metabolic bone disease (opens in a new tab)

  5. Spectrum of Microarchitectural Bone Disease in Inborn Errors of Metabolism

    … patients can often present with compromised bone health and an increased risk for fragility fractures. The current standard for measuring bone health in the general population is bone density assessed by dual-energy X-ray absorptiometry (DXA). However, its utilization in understanding bone …

    calgary Repository record for Spectrum of Microarchitectural Bone Disease in Inborn Errors of Metabolism (opens in a new tab)

  6. Development of Quantitative Bone SPECT Analysis Methods for Metastatic Bone Disease

    … types of cancer in males in the United States. Bone is a common site of metastases for metastatic prostate cancer. However, bone metastases are often considered “unmeasurable” using standard anatomic imaging and the RECIST 1.1 criteria. As a result, response to therapy is often suboptimally …

    jhu Repository record for Development of Quantitative Bone SPECT Analysis Methods for Metastatic Bone Disease (opens in a new tab)

  7. Investigation of metabolic bone disease by in vivo neutron activation analysis

    … for span alone to obtain an index reflecting the bone lost since the menopause, the osteopaenia index. Patients with vertebral fractures all had values below 0.78 and so this was considered the fracture threshold. A low mean value for CaR was found in 14 patients with primary hyperparathyroidism. …

    edinburgh Repository record for Investigation of metabolic bone disease by in vivo neutron activation analysis (opens in a new tab)

  8. Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease

    … a destructive and debilitating osteolytic bone disease. The bone disease is characterised by an increase in osteoclastogenesis and by osteoblast suppression. Current treatments for MM bone disease include bisphosphonates and denosumab, both of which act to inhibit osteoclast formation and …

    oxford Repository record for Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease (opens in a new tab)

  9. Myeloma-osteoclast interactions as a therapeutic target for multiple myeloma bone disease

    … plasma cells specifically migrate to the bone marrow, myeloma is often accompanied by osteodegenerative disease, which is characterized by an imbalance of bone resorption. Bone disease in multiple myeloma is driven by the dysregulated signaling of myeloma cells and the increased abundance …

    eastern-wash Repository record for Myeloma-osteoclast interactions as a therapeutic target for multiple myeloma bone disease (opens in a new tab)

  10. Evaluation of bone marrow lesions as a manifestation of subchondral bone disease

    To view the abstract, please see the full text of the document.

    colostate Repository record for Evaluation of bone marrow lesions as a manifestation of subchondral bone disease (opens in a new tab)

  11. TALLYHO/JngJ as a model for type 2 diabetes-induced bone disease

    Der Typ-2-Diabetes mellitus (T2DM) wird mit einem erhöhten Frakturrisiko in Verbindung gebracht, welches auf krankheitsspezifische Defizite in der Knochenmikrostruktur und -qualität zurückzuführen ist. Da die zugrundeliegenden Mechanismen unzureichend verstanden sind, kommen präklinische Modelle, …

    qucosa-diss

  12. Bone disease in HIV-infected individuals and the effects of antiretroviral therapy

    Bone loss and fractures are more common in HIV‐infected than HIV-uninfected adults. This thesis examined bone disease measures and related factors among HIV-infected adults who participated in two clinical trials of combination antiretroviral therapy. Three sub-studies in the STEAL trial …

    unsw Repository record for Bone disease in HIV-infected individuals and the effects of antiretroviral therapy (opens in a new tab)

  13. Incretin dysregulation of lysyl oxidase: a new mechanism for diabetic bone disease

    … and type 2 diabetics14. The changes in diabetic bone may be due to reductions in lysyl oxidase (LOX) levels leading to decreased amounts of insoluble type 1 collagen fibers, which are necessary for bone strength28. LOX catalyzes oxidative deamination of the hydroxylysine and lysine side chains of …

    bu Repository record for Incretin dysregulation of lysyl oxidase: a new mechanism for diabetic bone disease (opens in a new tab)

  14. Characterization of Bone Material Properties and Microstructure in Osteogenesis Imperfecta/Brittle Bone Disease

    … type I collagen and resulting in mild to severe bone fragility. To date, there is very little data quantifying OI cortical bone mechanics. The purpose of this dissertation was to investigate bone microstructure, mineralization, and mechanical properties in adolescents with OI. Characterization …

    marquette Repository record for Characterization of Bone Material Properties and Microstructure in Osteogenesis Imperfecta/Brittle Bone Disease (opens in a new tab)

  15. The role of sphingolipid metabolism in sickle bone disease and bone stem cells

    Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. SCD affects approximately 100,000 people domestically and an additional 300,000 babies born globally every year. A collection of pathologies, including osteonecrosis (ON), osteoporosis, and osteopenia, known …

    gatech Repository record for The role of sphingolipid metabolism in sickle bone disease and bone stem cells (opens in a new tab)

  16. Exploiting knowledge of mesenchymal stromal cells in vivo for bone disease therapy development

    … the nature of MSCs in vivo can be used to guide bone disease therapy development. It first address the unpredictable MSC content of bone marrow (BM) aspirates used for therapy; then examines MSC enrichment using clinical grade immunomagnetic cell selection. Induction of osteogenesis was …

    whiterose Download PDF for Exploiting knowledge of mesenchymal stromal cells in vivo for bone disease therapy development (opens in a new tab)

  17. A mutation in the gene encoding osteoprotegerin causes the severe bone disease Idiopathic Hyperphosphatasia

    … Hyperphosphatasia, a rare autosomal recessive bone disease, identified linkage to a region of chromosome 8q that contains the gene for osteoprotegerin (OPG), a key regulator of bone remodelling. Sequencing of this gene in members of the family identified an in-frame 3 base pair deletion …

    auckland-ms Repository record for A mutation in the gene encoding osteoprotegerin causes the severe bone disease Idiopathic Hyperphosphatasia (opens in a new tab)

  18. Subchondral Bone Disease and Osteoarthritis: Use of Large Animal Models, Novel Techniques, and Emerging Treatments

    <p>Development and progression of subchondral bone disease and osteoarthritis involve a combination of biomechanical forces, molecular signaling, and cellular interactions. The following pages explore current understanding of the complex interaction of subchondral bone and articular cartilage. An …

    utk-theses Repository record for Subchondral Bone Disease and Osteoarthritis: Use of Large Animal Models, Novel Techniques, and Emerging Treatments (opens in a new tab)

Page 1 of 14